Advancing the Use of Cancer Vaccines in Glioblastoma to Reprogram the Patient’s Immune System
- Designing vaccines to prime and activate the patient’s own immune system to recognize and attack specific GBM cells
- Identifying and utilizing GBM specific tumor antigens to develop targeted and effective vaccine strategies
- Focussing on GBM vaccines in combination with other modalities to overcome the TME and boost anti-tumor response